If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

Longwood Construction Notice: Ongoing construction near our Longwood campus may affect traffic in the area. Check the latest access changes before you travel.

The purpose of this research study is to evaluate the possible benefits and harms of screening with an investigational blood test designed to detect many types of cancer early. The name of the ...

We provide an abundance of opportunities for you to contribute to our mission to eradicate cancer and related disease. Our featured career areas include clinical jobs, research jobs, and admin and ...

This is a prospective, randomized, open-label phase II study comparing cognitive outcomes between men with metastatic and non-metastatic castration resistant prostate cancer (CRPC) or metastatic ...

Endometrial cancer, a type of uterine cancer, is the most common gynecologic disease diagnosed in the United States. The nationally recognized team of experts at Dana-Farber's Gynecologic Oncology ...

Palliative care is specialized medical care designed to improve your quality of life when you're managing a serious illness like cancer. It focuses on easing your symptoms and stress. You can receive ...

Donald J. Annino, MD, DMD - Surgical Oncology Dr Annino answered each question with a thirough explanation. He speaks with such an encouraging tone. He allows you to feel like each question Is ...

Jad El Masri, MD - Medical Oncology Dana-Farber Brigham Cancer Center at South Shore Health 101 Columbian Street South Weymouth, MA 02190 ...

After a cancer diagnosis, you may feel as though you have lost control of your body. This is a common reaction: not only may you be facing a life-threatening disease, but you may also be experiencing ...

Laurie H. Glimcher, MD, served as President and CEO of Dana-Farber Cancer Institute from 2016 to 2024 and is the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.